mesalamine
Term · Oncology and biomedicine · MLC-T-ONC-015101
An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and prostaglandin production. Following rectal or oral administration, only a small amount of mesalamine is absorbed; the remainder, acting topically, reduces bowel inflammation, diarrhea, rectal bleeding and stomach pain.
| Identifier | MLC-T-ONC-015101 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 5-ASA |
| Synonyms | mesalazine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015101",
"term": "mesalamine",
"field": "Oncology and biomedicine",
"definition": "An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and prostaglandin production. Following rectal or oral administration, only a small amount of mesalamine is absorbed; the remainder, acting topically, reduces bowel inflammation, diarrhea, rectal bleeding and stomach pain.",
"abbreviation": "5-ASA",
"synonyms": [
"mesalazine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mesalamine/"
}
Record 10,873 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.